Case Reports in Oncology (Jun 2020)

Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report

  • Afra M. Elhassan,
  • Arwa Alsaud,
  • Mohamed A. Yassin,
  • Mahmood Aldapt,
  • Lubna Riaz,
  • Firdous Ghori,
  • Aiman Bin Ahmad,
  • Mohammad Abdulla

DOI
https://doi.org/10.1159/000507651
Journal volume & issue
Vol. 13, no. 2
pp. 675 – 679

Abstract

Read online

Essential thrombocythemia (ET) is one of the myeloproliferative neoplasms, characterized by persistent thrombocytosis, platelets >450,000/μL, and evident clonal abnormalities like JAK2 V617F, MPL, CALR mutation and not fulfilling WHO criteria for MDS, CML, PV, and IDA. Here we report a 24-year-old female who presented with headache and was found to have thrombocytosis with a platelet count of 2,141 × 103/μL, diagnosed as ET as per WHO criteria 2008; she required ICU admission and thrombocytapheresis with a favorable outcome.

Keywords